Lung Cancers Withdrawn Phase 2 Trials for Irinotecan (DB00762)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01654081A Protocol of Irinotecan for Carcinoma of the LungTreatment